Which Nutrient Deficiency Is Behind Your Anemia: Iron, B12, or Folate

Anemia is not a single condition with a single cause. Iron, vitamin B12, and folate each play distinct roles in red blood cell production, and a shortfall in any one of them can leave you feeling fatigued and short of breath. Understanding which deficiency may be involved is the first step toward working with a clinician on the right approach.

How Each Nutrient Connects to Red Blood Cells

Iron

According to the NIH Office of Dietary Supplements (ODS), iron serves as an essential component of hemoglobin, the red blood cell protein that carries oxygen from the lungs to the tissues. It also forms part of myoglobin, a protein that supplies oxygen to muscle, and it supports physical growth and neurological development. When iron stores fall too low, the body cannot produce enough functional hemoglobin, and a type of anemia called iron-deficiency anemia results. The evidence that iron is essential for hemoglobin formation and oxygen transport is rated strong by the ODS.

Vitamin B12

The NIH ODS notes that vitamin B12 is required for healthy red blood cell formation, for the development, myelination, and function of the central nervous system, and for DNA synthesis. When B12 is insufficient, red blood cells grow abnormally large and cannot divide properly, producing what is known as megaloblastic anemia. The ODS rates the evidence that adequate B12 helps prevent megaloblastic anemia as strong. Notably, no Tolerable Upper Intake Level has been established for B12 because of its low potential for toxicity.

Folate (Vitamin B9)

Folate acts as a coenzyme in single-carbon transfers needed for DNA and RNA synthesis, and it enables the methylation step in DNA formation that is required for proper cell division. Like B12, insufficient folate disrupts cell division in the bone marrow and can also cause megaloblastic anemia. The ODS rates the evidence for folate's role as a coenzyme in DNA synthesis and normal cell division as strong.

Daily Targets and Upper Limits

The following reference values come from the NIH ODS and the National Academies Dietary Reference Intakes.

• Iron: 8 mg per day for men aged 19 to 50; 18 mg per day for women aged 19 to 50. The Tolerable Upper Intake Level is 45 mg per day for adults, based on gastrointestinal effects.
• Vitamin B12: 2.4 mcg per day for adults. No upper limit has been established.
• Folate: 400 mcg of dietary folate equivalents (DFE) per day for adults. The upper limit for synthetic folic acid from supplements and fortified foods is 1,000 mcg per day for adults.

These are population reference values. Please consult a clinician or pharmacist to determine what amount is appropriate for your individual situation.

Who Is at Greater Risk for Each Deficiency

Iron

The ODS notes that people in the United States usually obtain adequate iron from diet, and adults with normal intestinal function have very little risk of iron overload from food. Groups at higher risk for deficiency include pregnant women, frequent blood donors, and people with certain chronic diseases. The ODS rates evidence that daily iron supplementation reduces the risk of anemia in pregnant women as moderate, and that iron supplementation helps frequent blood donors recover hemoglobin and iron stores faster as moderate as well.

Vitamin B12

Older adults, people following strict plant-based diets, and those with conditions that reduce stomach acid production are among those at greater risk for B12 deficiency. The ODS also notes that people taking metformin or gastric acid inhibitors should discuss their B12 status with a health care provider.

Folate

People who consume little in the way of leafy vegetables, legumes, or fortified grains, as well as those who are pregnant or planning to become pregnant, are at higher risk. The ODS rates the evidence that adequate folic acid before conception and in early pregnancy helps prevent neural tube defects as strong.

Important Drug Interactions to Know

Always talk to a doctor or pharmacist before combining any supplement with a medication. The NIH ODS highlights the following interactions.

• Iron and levodopa: Iron supplements can reduce absorption of levodopa (found in Sinemet and Stalevo), possibly by chelation, and may diminish its clinical effectiveness.
• Iron and levothyroxine: Taking iron at the same time as levothyroxine (Synthroid, Levoxyl, and others) can reduce levothyroxine absorption. Labels advise separating iron by at least 4 hours.
• Iron and proton pump inhibitors: Drugs such as omeprazole (Prilosec) and lansoprazole (Prevacid) lower stomach acidity and can reduce nonheme iron absorption.
• Iron and calcium: Calcium may reduce the bioavailability of both nonheme and heme iron. Some experts suggest taking calcium and iron supplements at different times.
• B12 and metformin: Metformin might reduce vitamin B12 absorption and significantly lower serum B12 concentrations.
• B12 and gastric acid inhibitors: Both proton pump inhibitors and H2-receptor antagonists such as cimetidine (Tagamet) can interfere with B12 absorption from food.
• Folate and methotrexate: Folate supplements can interfere with methotrexate when it is used to treat cancer. Patients should consult their provider before supplementing.
• Folate and antiepileptic medications: Drugs such as phenytoin (Dilantin), carbamazepine (Tegretol), and valproate (Depacon) can reduce blood folate levels, and folate supplements can in turn reduce blood levels of these medications.
• Folate and sulfasalazine: Sulfasalazine (Azulfidine), used for ulcerative colitis, inhibits intestinal folate absorption and can cause folate deficiency.

A Critical Safety Note About Folate and B12

The ODS highlights a key concern: high folic acid intake can mask a vitamin B12 deficiency and allow irreversible nerve damage to progress undetected. This is one of the primary reasons the upper limit for synthetic folic acid is set at 1,000 mcg per day for adults, and it is a strong reason to have blood levels tested before supplementing with either nutrient at high doses.

What the Evidence Does Not Support

It is worth being clear about the limits of the research. The ODS rates evidence for B12 supplementation reducing cardiovascular disease risk, improving cognitive function, or boosting energy in people who are not deficient as insufficient. For folate, evidence that supplements improve cognitive function or prevent dementia is also rated insufficient. These supplements are not intended to diagnose, treat, cure, or prevent any disease, and these statements have not been evaluated by the FDA.

Next Steps

If you are experiencing persistent fatigue, weakness, or other symptoms that concern you, the most reliable way to identify a deficiency is through blood testing ordered by a clinician. A complete blood count combined with serum ferritin, serum B12, and folate measurements can help distinguish between these three causes. Self-diagnosing and self-treating anemia carries real risks, particularly around the B12 and folate masking issue described above. Work with a health care provider to identify the root cause before starting any supplementation program.